{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:08:03Z","timestamp":1792728483199,"version":"4.5.0"},"reference-count":52,"publisher":"American Psychiatric Association Publishing","issue":"1","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R34 DA046730"],"award-info":[{"award-number":["R34 DA046730"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA013035"],"award-info":[{"award-number":["UG1DA013035"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA013714"],"award-info":[{"award-number":["UG1DA013714"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA013727"],"award-info":[{"award-number":["UG1DA013727"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA015831"],"award-info":[{"award-number":["UG1DA015831"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psych Res and Clin Practice"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The opioid epidemic continues to evolve and impact all groups of people. Moreover, there are concerning trends among women. The aim of this article is to provide a review of opioid use disorder in women and the implications for treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A nonsystematic review of the literature as conducted to examine: (1) the epidemiology of opioid\u2010related hospitalizations and deaths of women; (2) co\u2010occurring pain, anxiety disorders, and trauma among women with opioid use disorder; (3) evidence for opioid agonist treatment of pregnant women with opioid use disorder; and (4) implications for treatment of women with opioid use disorder and next steps for research and practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The current opioid epidemic has produced important differences by sex and gender with increased rates of use and overdose deaths in women. Significant mental health concerns for women include co\u2010occurring psychiatric disorders and suicide. Expanding medication treatment for perinatal opioid use disorder is crucial. While effective treatments exist for opioid use disorder, they are often not accessible, and a minority of patients are treated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The end to the opioid epidemic will require innovative multi\u2010systemic solutions. There are significant practice gaps in preventing rising death rates among women by opioid overdose, treating co\u2010occurring psychiatric disorders and pain, and treating perinatal women with opioid use disorder and their infants. Research on sex and gender differences, and the intersection with race\/ethnicity and US region, is critically needed and should include treatment implementation studies to achieve wider access for women to effective prevention, early intervention, and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1176\/appi.prcp.20190051","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T12:10:01Z","timestamp":1602591001000},"page":"3-11","source":"Crossref","is-referenced-by-count":73,"title":["Opioid Use Disorder in Women and the Implications for Treatment"],"prefix":"10.1176","volume":"3","author":[{"given":"Celestina","family":"Barbosa\u2010Leiker","sequence":"first","affiliation":[{"name":"College of Nursing Washington State University  Spokane"},{"name":"Program of Excellence in Addictions Research Washington State University  Spokane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee N. C.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Columbia University Irving Medical Center New York State Psychiatric Institute  New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Kathryn","family":"McHugh","sequence":"additional","affiliation":[{"name":"Department of Psychiatry McLean Hospital Harvard Medical School  Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Guille","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology Medical University of South Carolina  Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly F.","family":"Greenfield","sequence":"additional","affiliation":[{"name":"Department of Psychiatry McLean Hospital Harvard Medical School  Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"e_1_2_7_1_2_1","unstructured":"National Institute on drug abuse: Overdose death rates 2019.https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates"},{"key":"e_1_2_7_1_3_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6801a1"},{"key":"e_1_2_7_1_4_1","unstructured":"Office of Women's Health: Final report: opioid use misuse and overdose in women citing 2017 CDC analysis of the national vital statistics system multiple cause of death data wide\u2010ranging OnLine data for epidemiologic research (WONDER) 2017"},{"key":"e_1_2_7_1_5_1","unstructured":"CDC: Vital signs: today's heroin epidemic 2015.https:\/\/www.cdc.gov\/vitalsigns\/heroin\/index.html"},{"key":"e_1_2_7_1_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2011.596875"},{"key":"e_1_2_7_1_7_1","unstructured":"National Institutes of Health Office of Research on Women's Health: Sex and gender 2020.https:\/\/orwh.od.nih.gov\/sex-gender"},{"key":"e_1_2_7_1_8_1","unstructured":"NIH National Institute on Drug Abuse: Overdose death rates 2019.https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates"},{"key":"e_1_2_7_1_9_1","volume-title":"Annual Surveillance Report of Drug\u2010Related Risks and Outcomes\u2014United States Surveillance Special Report","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"e_1_2_7_1_10_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-1812"},{"key":"e_1_2_7_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2012.07.007"},{"key":"e_1_2_7_1_12_1","volume-title":"Opioid\u2010Related Hospital Stays Among Women, 2016","author":"Weiss AJ","year":"2019"},{"key":"e_1_2_7_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2010.01.004"},{"key":"e_1_2_7_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32812-X"},{"key":"e_1_2_7_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2012.12.007"},{"key":"e_1_2_7_1_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12784"},{"key":"e_1_2_7_1_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12921"},{"key":"e_1_2_7_1_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01711.x"},{"key":"e_1_2_7_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2011.03.006"},{"key":"e_1_2_7_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.12.030"},{"key":"e_1_2_7_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.07.007"},{"key":"e_1_2_7_1_22_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6736a2"},{"key":"e_1_2_7_1_23_1","unstructured":"National Institute on Drug Abuse: Benzodiazepines and opioids 2018.https:\/\/www.drugabuse.gov\/drugs-abuse\/opioids\/benzodiazepines-opioids#graph"},{"key":"e_1_2_7_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2018.08.010"},{"key":"e_1_2_7_1_25_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6801a1"},{"issue":"1","key":"e_1_2_7_1_26_1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1176\/ajp.2007.164.1.100","article-title":"A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence","volume":"164","author":"Weiss RD","year":"2007","journal-title":"Am J Psychiatry"},{"key":"e_1_2_7_1_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.9071"},{"issue":"2","key":"e_1_2_7_1_28_1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/00952990.2011.643990","article-title":"Profiles of distress intolerance in a substance\u2010dependent sample","volume":"38","author":"McHugh RK","year":"2012","journal-title":"Am J Drug Alcohol Abuse"},{"key":"e_1_2_7_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2016.03.004"},{"key":"e_1_2_7_1_30_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2010.535581"},{"key":"e_1_2_7_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.05.012"},{"key":"e_1_2_7_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.06.035"},{"key":"e_1_2_7_1_33_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6731a1"},{"key":"e_1_2_7_1_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000472"},{"issue":"4","key":"e_1_2_7_1_35_1","first-page":"2017","article-title":"Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004\u20102014","volume":"141","author":"Winkelman TNA","year":"2018","journal-title":"Pediatrics"},{"key":"e_1_2_7_1_36_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6531a2"},{"key":"e_1_2_7_1_37_1","volume-title":"Clinical Guidance for Treating Pregnant Women with Opioid Use Disorder and Their Infants (HHS Publ No SMA\u201018\u20105054)","author":"Substance Abuse and Mental Health Services Administration","year":"2018"},{"key":"e_1_2_7_1_38_1","unstructured":"US Department of Health and Human Services National Institutes of Health: Consensus development conference statement effective medical treatment of opiate addiction Nov 17\u201019 1997.https:\/\/consensus.nih.gov\/1997\/1998TreatOpiateAddiction108html"},{"key":"e_1_2_7_1_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005359"},{"key":"e_1_2_7_1_40_1","first-page":"CD006318","article-title":"Maintenance agonist treatments for opiate\u2010dependent pregnant women","volume":"12","author":"Minozzi S","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_1_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13462"},{"issue":"1","key":"e_1_2_7_1_42_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1176\/appi.prcp.20180004","article-title":"Shared decision\u2010making tool for treatment of perinatal opioid use disorder","volume":"1","author":"Guille CJH","year":"2018","journal-title":"Psychiatric Res Clinical Prac"},{"key":"e_1_2_7_1_43_1","unstructured":"NIH National Institute on Drug Abuse: Medication Treatment for Opioid\u2010dependent Expecting Mothers (MOMs): A Pragmatic Randomized Trial Comparing Two Buprenorphine Formulations.https:\/\/www.drugabuse.gov\/about-nida\/organization\/cctn\/ctn\/research-studies\/medication-treatment-opioid-dependent-expecting-mothers-moms-pragmatic-randomized-trial-comparing"},{"key":"e_1_2_7_1_44_1","unstructured":"CDC: Opioid overdose: understanding the epidemic August 30 2017.https:\/\/www.cdc.gov\/drugoverdose\/epidemic\/index.html"},{"key":"e_1_2_7_1_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1402780"},{"key":"e_1_2_7_1_46_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6801a1"},{"key":"e_1_2_7_1_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1801417"},{"key":"e_1_2_7_1_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1802148"},{"issue":"3","key":"e_1_2_7_1_49_1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2105\/AJPH.2016.303591","article-title":"Suicide deaths with opioid poisoning in the United States: 1999\u20102014","volume":"107","author":"Braden JB","year":"2017","journal-title":"Am J Publ Health"},{"key":"e_1_2_7_1_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2010.06.018"},{"key":"e_1_2_7_1_51_1","unstructured":"WeissAJBM O'MalleyL BarrettML et al: Patient Characteristics of opioid related inpatient stays and emergency department visits nationally and by state 2014. Statistical Brief #224. Healthcare Cost and Utilization Project. June 2017"},{"key":"e_1_2_7_1_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.121"},{"key":"e_1_2_7_1_53_1","volume-title":"Treating Women with Substance Use Disorders: The Women's Recovery Group Manual","author":"Greenfield SF","year":"2016"}],"container-title":["Psychiatric Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1176\/appi.prcp.20190051","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1176\/appi.prcp.20190051","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1176\/appi.prcp.20190051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:15:19Z","timestamp":1778696119000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1176\/appi.prcp.20190051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1176\/appi.prcp.20190051"],"URL":"https:\/\/doi.org\/10.1176\/appi.prcp.20190051","archive":["Portico"],"relation":{},"ISSN":["2575-5609","2575-5609"],"issn-type":[{"value":"2575-5609","type":"print"},{"value":"2575-5609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,13]]}}}